#University of Colorado Cancer Center

Drugs developed to target particular genetic changes may not be right for every person whose cancer shows those alterations or mutations.

Thanks to groundbreaking immunotherapy research, Jane Hart enjoys every day without laryngeal cancer.

November is Pancreatic Cancer Awareness Month. Laura Foote shares her story to bring hope and express gratitude.

The Prostate Specific Membrane Antigen (PSMA) PET Scan more accurately locates cancerous cells and tumors, improving targeted treatments.

Despite confusing media coverage of a study relating to colonoscopies, they are an effective tool in reducing colorectal cancer risk.

Music teacher Winona Williams lives a life not dominated by her ovarian cancer diagnosis—and she hopes her treatment will help others.

Elena Shagisultanova, MD, PhD, answers six questions about the importance of mammograms, the challenges of dense breasts and more.

The CU Cancer Center was one of the clinical trial sites for Optune, which creates electrical fields that stop cancer cells from dividing.

The levels of prostate-specific antigen in the blood can indicate further testing is needed to screen for cancer.

Two cancer specialists detail how the Supreme Court ruling against abortion access will harm some patients.

“This is simply a blood draw.” Analyzing plasma to define gene mutations in breast cancer is less invasive than tissue biopsies.

Federally funded research aims to understand the effects of psilocybin on depression and anxiety in people with cancer.

If not, you aren’t alone according to a study that assessed patient understanding of common terms such as “carcinoma” and “metastatic....

Members of the ALK-positive lung cancer community gathered at a summit to learn new developments and nurture support.

Research also shows that liso-cel (Breyanzi) is significantly superior to an autotransplant for some patients with large B-cell lymphoma.

How a CU Cancer Center clinical trial saved Ward McNeilly’s life. Plus: Sarcomas explained.